About the Product

Description


Cefactor 250 Syrup containing Cefaclor is used for the management of bacterial infections in children. It helps control infection-causing bacteria and supports faster recovery from common pediatric infections.

Cefaclor works as a second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, thereby helping eliminate susceptible bacteria effectively.

The syrup is widely prescribed in pediatric practice for respiratory tract infections, ear infections, throat infections, skin infections, and other bacterial conditions, leading to consistent prescription demand.

With increasing prevalence of pediatric bacterial infections and growing demand for child-friendly antibiotic formulations, this product offers strong business potential for retailers and distributors. Its established antibacterial action, broad therapeutic relevance, and steady market demand make it a reliable product for growth in the pediatric anti-infective segment.

Some patients may experience nausea, vomiting, diarrhea, abdominal discomfort, rash, headache, or dizziness. Rarely, severe allergic reactions, antibiotic-associated colitis, blood-related disorders, or liver function abnormalities may occur and require immediate medical attention.

Cefactor 250 Syrup is indicated for respiratory tract infections, ear infections, throat infections, sinusitis, urinary tract infections, skin and soft tissue infections, and other bacterial infections caused by susceptible organisms. It helps eliminate infection-causing bacteria and relieve associated symptoms.

This medicine should be used strictly under medical supervision. Shake well before use and follow the prescribed dosage carefully. Complete the full prescribed course even if symptoms improve early to prevent antibiotic resistance. Use cautiously in patients with a history of cephalosporin or penicillin allergy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the bottle tightly closed and out of reach of children. Reconstituted syrup should be used within the period recommended on the label and stored as directed.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Cefaclor 250mg Syrup in the PCD pharma franchise market?

Cefaclor 250mg Syrup has strong demand in the pediatric, anti-infective, ENT, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on pediatric antibiotic portfolios.

Why should medical distributors include Cefaclor 250mg Syrup in their product range?

Medical distributors and agencies can benefit from consistent demand for bacterial infection management in children under medical supervision. Cefaclor 250mg is a second-generation cephalosporin antibiotic with broad-spectrum antibacterial activity Commonly prescribed for otitis media (ear infections), tonsillitis, pharyngitis, respiratory tract infections, urinary tract infections, and skin & soft tissue infections caused by susceptible bacteria Syrup formulation ensures easy administration and improved patient compliance in pediatric patients Frequently prescribed by pediatricians, ENT specialists, and general physicians This strengthens a comprehensive pediatric and anti-infective portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this syrup?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Cefaclor 250mg Syrup with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong pediatric prescription demand, repeat purchases, seasonal infection management opportunities, reliable supply chain support, and attractive margins in the antibiotic segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.